跳至主要内容
临床试验/ISRCTN76889861
ISRCTN76889861已完成未知

Observing fibrosis, macular atrophy and sub retinal highly reflective material before and after intervention with anti-VEGF treatment - an extension to the EDNA study

York Teaching Hospital NHS Foundation Trust0 个研究点目标入组 431 人开始时间: 2017年5月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
431

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. The patient must have been enrolled into EDNA
  • 2. Individuals aged 50 and over with newly diagnosed nvAMD with one eye affected and one eye unaffected who are about to commence or have recently commence anti-VEGF therapy in the affected eye
  • 3. Exit from EDNA must be less than or equal to 12 months prior to enrolment into FASBAT
  • 4. The patient must be willing to enter FASBAT and able to provide data and attend assessment clinics for a further 2 years following the exit of EDNA

排除标准

  • 1. nvAMD in study eye detected at baseline for the EDNA study
  • 2. Presenting worse than 68 letters at baseline in the EDNA study
  • 3. Retinal or media pathology in either eye that will prevent sufficient quality of imaging (in the view of the investigator)
  • 4. Not undergoing regular monitoring in standard of care
  • 5. FFA contraindicated

研究者

相似试验